Current and completed investments

Sciety is specialised in growth companies within life science. We invest in biotechnology, digital health, ICT in healthcare, pharmaceuticals and medical technology.

Current investments

Receive information about upcoming investment opportunities

Sign up below to get information about upcoming investment opportunities and invitations to investor lunches with the company's management.

Completed investments

Cavis Technologies

Cavis Technologies has developed a combined guidewire/catheter, Wirecath®, for diagnosis of people with coronary heart disease. Wirecath® is expected to provide important clinical benefits.

Sciety_invests_in_Elypta

Elypta

Elypta has developed a new method for early cancer diagnosis. Liquid Biopsy is a rapidly growing field that is expected to be of great importance for cancer diagnosis.

Athera Biotechnologies

The company is in Phase II with a pharmaceutical candidate for a life-threatening illness for which there are currently no sufficient therapies.

Sciety_Predicare-RETTS

Predicare

Predicare is the company behind the system RETTS©, used by 95% of Sweden’s hospitals and ambulances. RETTS© daily helps healthcare professionals to make the right decisions in emergency situations.

Exits

Inhalation Sciences

Inhalation Sciences’ technology is used by prominent players within the chemical and pharma sectors to study how airborne particles impact the human body.

Attana

With Attana’s patented technology, pharmaceutical companies can evaluate, in an early development stage, how drug candidates impact the body and can identify the risk of side effects.

Raytelligence

Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company is aimed at elderly care in the home.